Clinical recrudescence of chronic untreated P. malariae infection after BNT162b2 CoVID-19 vaccine

We described a case of clinical reactivation of chronic P. malariae infection following CoVID-19 vaccination with BNT162b2 (Pifzer-Biontech CoVID-19 vaccine) in a 48-year old Italian man.The patient came to our attention for fever of unknown origin show a quartan pattern (every third day) associated...

Descripción completa

Detalles Bibliográficos
Autores principales: Ciusa, G., Guida Marascia, F., Virruso, R., Angheben, A., Guaraldi, G., Cascio, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857774/
https://www.ncbi.nlm.nih.gov/pubmed/35223428
http://dx.doi.org/10.1016/j.idcr.2022.e01456
_version_ 1784654110053629952
author Ciusa, G.
Guida Marascia, F.
Virruso, R.
Angheben, A.
Guaraldi, G.
Cascio, A.
author_facet Ciusa, G.
Guida Marascia, F.
Virruso, R.
Angheben, A.
Guaraldi, G.
Cascio, A.
author_sort Ciusa, G.
collection PubMed
description We described a case of clinical reactivation of chronic P. malariae infection following CoVID-19 vaccination with BNT162b2 (Pifzer-Biontech CoVID-19 vaccine) in a 48-year old Italian man.The patient came to our attention for fever of unknown origin show a quartan pattern (every third day) associated to splenomegaly, the onset of the fever occurred one month after CoVID-19 vaccination with BNT162b2. P. malariae was diagnosed using Carestart™ malaria rapid test and Polymerase-Chain Reaction. Post-vaccine transient reduction of immune reactivity is described in literature, although the mechanism is unknown.
format Online
Article
Text
id pubmed-8857774
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-88577742022-02-22 Clinical recrudescence of chronic untreated P. malariae infection after BNT162b2 CoVID-19 vaccine Ciusa, G. Guida Marascia, F. Virruso, R. Angheben, A. Guaraldi, G. Cascio, A. IDCases Case Report We described a case of clinical reactivation of chronic P. malariae infection following CoVID-19 vaccination with BNT162b2 (Pifzer-Biontech CoVID-19 vaccine) in a 48-year old Italian man.The patient came to our attention for fever of unknown origin show a quartan pattern (every third day) associated to splenomegaly, the onset of the fever occurred one month after CoVID-19 vaccination with BNT162b2. P. malariae was diagnosed using Carestart™ malaria rapid test and Polymerase-Chain Reaction. Post-vaccine transient reduction of immune reactivity is described in literature, although the mechanism is unknown. Elsevier 2022-02-19 /pmc/articles/PMC8857774/ /pubmed/35223428 http://dx.doi.org/10.1016/j.idcr.2022.e01456 Text en © 2022 The Authors. Published by Elsevier Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Ciusa, G.
Guida Marascia, F.
Virruso, R.
Angheben, A.
Guaraldi, G.
Cascio, A.
Clinical recrudescence of chronic untreated P. malariae infection after BNT162b2 CoVID-19 vaccine
title Clinical recrudescence of chronic untreated P. malariae infection after BNT162b2 CoVID-19 vaccine
title_full Clinical recrudescence of chronic untreated P. malariae infection after BNT162b2 CoVID-19 vaccine
title_fullStr Clinical recrudescence of chronic untreated P. malariae infection after BNT162b2 CoVID-19 vaccine
title_full_unstemmed Clinical recrudescence of chronic untreated P. malariae infection after BNT162b2 CoVID-19 vaccine
title_short Clinical recrudescence of chronic untreated P. malariae infection after BNT162b2 CoVID-19 vaccine
title_sort clinical recrudescence of chronic untreated p. malariae infection after bnt162b2 covid-19 vaccine
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857774/
https://www.ncbi.nlm.nih.gov/pubmed/35223428
http://dx.doi.org/10.1016/j.idcr.2022.e01456
work_keys_str_mv AT ciusag clinicalrecrudescenceofchronicuntreatedpmalariaeinfectionafterbnt162b2covid19vaccine
AT guidamarasciaf clinicalrecrudescenceofchronicuntreatedpmalariaeinfectionafterbnt162b2covid19vaccine
AT virrusor clinicalrecrudescenceofchronicuntreatedpmalariaeinfectionafterbnt162b2covid19vaccine
AT anghebena clinicalrecrudescenceofchronicuntreatedpmalariaeinfectionafterbnt162b2covid19vaccine
AT guaraldig clinicalrecrudescenceofchronicuntreatedpmalariaeinfectionafterbnt162b2covid19vaccine
AT cascioa clinicalrecrudescenceofchronicuntreatedpmalariaeinfectionafterbnt162b2covid19vaccine

Ejemplares similares